Low-grade non-Hodgkin lymphomas and their cytofunctional correlation with the peripheral compartments of normal lymphoid tissue

被引:0
|
作者
Fayos, JS
Barbero, AR
Calabuig, MPSF
deOzaeta, CS
Hernanz, JO
机构
来源
REVISTA CLINICA ESPANOLA | 1995年 / 195卷 / 12期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:864 / 872
页数:9
相关论文
共 50 条
  • [1] Low-grade non-Hodgkin lymphomas
    Tsang, Richard W.
    Gospodarowicz, Mary K.
    SEMINARS IN RADIATION ONCOLOGY, 2007, 17 (03) : 198 - 205
  • [2] Prognostic factors in low-grade non-Hodgkin lymphomas
    Federico M.
    Molica S.
    Bellei M.
    Luminari S.
    Current Hematologic Malignancy Reports, 2009, 4 (4) : 202 - 210
  • [3] Prognostic parameters in low-grade non-Hodgkin's lymphomas
    Zemunik, T
    Vuckovic, J
    Forenpoher, G
    Knezevic, N
    Stula, N
    Dubravcic, M
    Ribicic, I
    Rozga, A
    NEOPLASMA, 1997, 44 (01) : 13 - 17
  • [4] NON-HODGKIN LYMPHOMAS WITH LOW-GRADE MALIGNANCY, SOME MIMICKING GLOMANGIOMAS
    STIEFEL, A
    HARTSCHUH, W
    DORKEN, B
    HAUTARZT, 1988, 39 (06): : 384 - 387
  • [5] Radiation therapy for localized low-grade non-Hodgkin's lymphomas
    Tsang, RW
    Gospodarowicz, MK
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (01) : 10 - 17
  • [6] Treatment options for primary splenic low-grade non-Hodgkin's lymphomas
    Musteata, VG
    Corcimaru, IT
    Iacovleva, IA
    Musteata, LZ
    Suharschii, IS
    Antoci, LT
    CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (06): : 397 - 401
  • [7] Clinical experience with oral idarubicin in low-grade non-Hodgkin's lymphomas
    Case, DC
    ORAL CYTOTOXIC TREATMENT IN HAEMATOLOGICAL MALIGNANCIES, 1996, 18 (03): : 35 - 41
  • [9] Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia
    Bello, Celeste
    Veliz, Marays
    Pinilla-Ibarz, Javier
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 295 - 300
  • [10] Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas
    Heider, A
    Niederle, N
    ANTI-CANCER DRUGS, 2001, 12 (09) : 725 - 729